Stay updated on ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Sign up to get notified when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.

Latest updates to the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page
- Check3 days agoChange DetectedAdded revision v3.3.4 to the history; the prior revision v3.3.3 was removed from the history display.SummaryDifference0.1%

- Check10 days agoChange DetectedVersion 13 (2025-12-11) shows termination for business reasons and the posting of results, including Outcome Measures (Results) and Baseline Characteristics. These updates reflect a change in study status and the availability of results data.SummaryDifference0.9%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe latest revision adds Revision: v3.3.3 to the history and removes HHS Vulnerability Disclosure and the older Revision: v3.3.2 from the footer; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check32 days agoChange DetectedRecord History gains new sections for Outcome Measures (Results) and Study Status, with updates dated 2025-11-25 and 2025-12-10, and a Quality Control Review status of Has Not Concluded.SummaryDifference0.7%

- Check47 days agoChange DetectedVersion 11 (2025-11-12) adds Adverse Events, Outcome Measures (Results), Outcome Measures, and Study Status, with a 'Quality Control Review Has Not Concluded' note. The previous revision v3.3.1 was removed from the history.SummaryDifference0.9%

- Check54 days agoChange DetectedThe page history now shows a new revision (v3.3.1) added and an earlier revision (v3.2.0) removed, reflecting an update to the revision log rather than changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.